Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases

Details for Australian Patent Application No. 2008201523 (hide)

Owner Eli Lilly and Company

Inventors Bellotti, Marc; Cham, Bill E.; Maltais, Jo-Ann B.

Agent FB Rice

Pub. Number AU-B-2008201523

Parent 2004264842

Filing date 3 April 2008

Wipo publication date 1 May 2008

Acceptance publication date 28 July 2011

International Classifications

C07K 14/155 (2006.01) Peptides having more than 20 amino acids

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 35/24 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Mucus

A61K 35/26 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Lymph

A61K 35/48 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Reproductive organs

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/002 (2006.01) Medicinal preparations containing antigens or antibodies - Protozoa antigens

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 39/215 (2006.01) Medicinal preparations containing antigens or antibodies - Coronaviridae, e.g. avian infectious bronchitis virus

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61L 2/00 (2006.01) Disinfection or sterilising

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/08 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/02 Antiparasitic agents

Event Publications

24 April 2008 Complete Application Filed

1 May 2008 Application Open to Public Inspection

  Published as AU-B-2008201523

6 August 2009 Assignment before Grant

  Lipid Sciences, Inc. The application has been assigned to Eli Lilly and Company

28 July 2011 Application Accepted

  Published as AU-B-2008201523

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201524-Population of transgenic plants, biological material derived therefrom, corresponding plasmid collection and population of transformed host organisms, use thereof and methods for producing the same

2008201522-Detection of small nucleic acids